Latest Period
Q4 2025
Security Snapshot
PRECISION BIOSCIENCES INC - Common Stock, $0.000005 par value per share (DTIL) Institutional Ownership
CUSIP: 74019P207
13F Institutional Holders and Ownership History from Q1 2024 to Q1 2026
Institutions Reporting
67
Shares (Excl. Options)
15,096,207
Price
$4.16
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Type / Class
- Equity / Common Stock, $0.000005 par value per share
- Symbol
- DTIL on Nasdaq
- Shares outstanding
- 25,804,443
- Price per share
- $5.50
- All holders as of 31 Dec 2025
- Q4 2025
- Total 13F shares
- 15,096,207
- Total reported value
- $62,794,720
- % of total 13F portfolios
- 0%
- Share change
- +8,251,010
- Value change
- +$33,303,415
- Number of holders
- 67
- Price from insider filings
- $5.50
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Quick Takeaways
- DTIL - PRECISION BIOSCIENCES INC - Common Stock, $0.000005 par value per share is tracked under CUSIP 74019P207.
- 67 institutions reported positions in Q4 2025.
- 9 significant owners is listed from Schedule 13D/13G reporting.
What Changed
- Holder count moved from 67 to 14 between Q4 2025 and Q1 2026.
- Reported value moved from $62,794,720 to $18,934,427.
Why This Matters
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Source Evidence
Source: SEC Form 13F
Open SEC Evidence
Latest holder context comes from 67 institutions filings for Q4 2025.
Investment Quick Answers
What is CUSIP 74019P207?
CUSIP 74019P207 identifies DTIL - PRECISION BIOSCIENCES INC - Common Stock, $0.000005 par value per share in SEC 13F datasets.
Where can I see the latest institutional holders?
Review the Q4 2025 holders report and the ownership history table below.
Next ownership checks
Use the next link that matches the question you still need to answer about this security.
- Latest 13F filings when you want to inspect fresh institutional portfolio moves.
- Latest Schedule 13D/13G reports when you need large-owner changes outside the 13F cycle.
- All institutional ownership pages to compare this security with other holder-history pages.
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 74019P207:
Significant Owners of PRECISION BIOSCIENCES INC - Common Stock, $0.000005 par value per share (DTIL) based on Schedule 13D/G filings
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| Octagon Capital Advisors LP | 10% | $9,570,073 | 2,328,485 | Octagon Capital Advisors LP | 31 Dec 2025 | |||
| Aberdeen Group plc | 8.9% | $8,896,588 | 2,138,603 | Aberdeen Group plc | 31 Dec 2025 | |||
| Empery Asset Management, LP | 7.6% | -24% | $10,828,834 | -$1,808,961 | 1,968,879 | -14% | Empery Asset Management, LP | 31 Mar 2026 |
| Bleichroeder LP | 8.2% | -15% | $7,809,000 | +$3,390,750 | 1,900,000 | +77% | Bleichroeder LP | 31 Dec 2025 |
| Readout Capital, LP | 9.4% | +5.6% | $4,980,934 | +$829,645 | 1,119,311 | +20% | Matthew Smith | 30 Jun 2025 |
| Lynx1 Capital Management LP | 4.1% | -52% | $4,084,982 | -$200,087 | 993,913 | -4.7% | Lynx1 Capital Management LP | 31 Dec 2025 |
| NOVARTIS PHARMA AG | 3.7% | -34% | $1,840,435 | 413,581 | 0% | Novartis Pharma AG | 30 Jun 2025 | |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 3.7% | $2,165,312 | 406,250 | Highbridge Capital Management, LLC | 31 Mar 2025 | |||
| Weinstein Benjamin | 5.2% | $2,107,956 | 395,489 | Weinstein Benjamin | 18 Mar 2025 |
As of 31 Dec 2025, 67 institutional investors reported holding 15,096,207 shares of PRECISION BIOSCIENCES INC - Common Stock, $0.000005 par value per share (DTIL). This represents 59% of the company’s total 25,804,443 outstanding shares.
Top 25 Institutional Shareholders
The largest institutional shareholders of PRECISION BIOSCIENCES INC - Common Stock, $0.000005 par value per share (DTIL) together control 56% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| Empery Asset Management, LP | 8.5% | 2,194,635 | 0% | 8.1% | $9,129,682 |
| Aberdeen Group plc | 8.3% | 2,138,603 | 0.01% | $8,896,588 | |
| Octagon Capital Advisors LP | 7.4% | 1,917,995 | 1% | $7,978,859 | |
| Bleichroeder LP | 6.4% | 1,662,500 | +55% | 1.2% | $6,916,000 |
| BOOTHBAY FUND MANAGEMENT, LLC | 4.1% | 1,066,050 | +497% | 0.12% | $4,434,768 |
| Lynx1 Capital Management LP | 3.9% | 993,913 | -4.7% | 0.84% | $4,134,678 |
| VANGUARD GROUP INC | 3.5% | 906,782 | +84% | 0% | $3,772,213 |
| Alyeska Investment Group, L.P. | 3.1% | 798,000 | 0.01% | $3,319,680 | |
| Driehaus Capital Management LLC | 3.1% | 787,700 | 0.02% | $3,276,832 | |
| SPHERA FUNDS MANAGEMENT LTD. | 1.5% | 396,116 | 0.34% | $1,647,843 | |
| RENAISSANCE TECHNOLOGIES LLC | 1.3% | 326,477 | +66% | 0% | $1,358,144 |
| GEODE CAPITAL MANAGEMENT, LLC | 0.87% | 225,657 | +106% | 0% | $938,763 |
| BlackRock, Inc. | 0.65% | 168,331 | +71% | 0% | $700,256 |
| TWO SIGMA INVESTMENTS, LP | 0.54% | 139,531 | +68% | 0% | $580,449 |
| MORGAN STANLEY | 0.39% | 99,805 | +853% | 0% | $415,189 |
| 683 Capital Management, LLC | 0.38% | 97,085 | 0.03% | $403,874 | |
| COMMONWEALTH EQUITY SERVICES, LLC | 0.36% | 93,306 | +67% | 0% | $388,150 |
| NORTHERN TRUST CORP | 0.34% | 86,464 | +127% | 0% | $359,690 |
| TWO SIGMA ADVISERS, LP | 0.32% | 83,443 | +60% | 0% | $347,123 |
| MARSHALL WACE, LLP | 0.27% | 70,915 | 0% | $295,004 | |
| Quarry LP | 0.26% | 68,311 | +15% | 0.07% | $284,174 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 0.26% | 66,581 | 0% | $276,977 | |
| Quadrature Capital Ltd | 0.24% | 62,129 | +345% | 0% | $258,457 |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 0.24% | 61,901 | 0% | 0.01% | $257,508 |
| UBS Group AG | 0.24% | 61,332 | +151% | 0% | $255,141 |
Institutional Holders of PRECISION BIOSCIENCES INC - Common Stock, $0.000005 par value per share (DTIL) across Reporting Periods
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q1 | 3,442,623 | $18,934,427 | +$676,914 | $5.50 | 14 |
| 2025 Q4 | 15,096,207 | $62,794,720 | +$33,303,415 | $4.16 | 67 |
| 2025 Q3 | 4,649,562 | $25,664,758 | +$1,234,800 | $5.52 | 54 |
| 2025 Q2 | 4,437,938 | $18,638,020 | +$2,152,791 | $4.20 | 51 |
| 2025 Q1 | 3,786,321 | $18,062,451 | +$340,769 | $4.77 | 47 |
| 2024 Q4 | 3,859,340 | $14,708,103 | -$4,075,765 | $3.81 | 51 |
| 2024 Q3 | 3,323,629 | $29,812,914 | +$1,425,206 | $8.96 | 50 |
| 2024 Q2 | 3,161,323 | $30,774,875 | -$108,215 | $9.73 | 45 |
| 2024 Q1 | 3,155,622 | $42,757,614 | +$42,755,553 | $13.56 | 40 |